{"ticker": "AWH", "overview": {"cik": "926617", "ticker": "AWHL", "name": "Aspira Women's Health Inc.", "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "sic": "2835", "announcements": [{"form": "4", "date": "2026-10-02", "title": "Insider transaction", "accession": "0001493152-26-045579", "price_sensitive": false}, {"form": "10-Q", "date": "2026-08-14", "title": "Quarterly report", "accession": "0000926617-26-000054", "price_sensitive": true}, {"form": "4/A", "date": "2026-07-17", "title": "Form 4/A", "accession": "0001493152-26-033814", "price_sensitive": false}, {"form": "4", "date": "2026-07-15", "title": "Insider transaction", "accession": "0001493152-26-033384", "price_sensitive": false}, {"form": "8-K", "date": "2026-07-15", "title": "Material event", "accession": "0000926617-26-000052", "price_sensitive": true}, {"form": "3", "date": "2026-07-15", "title": "Initial insider holdings", "accession": "0001493152-26-033355", "price_sensitive": false}, {"form": "8-K/A", "date": "2026-07-07", "title": "Form 8-K/A", "accession": "0000926617-26-000050", "price_sensitive": false}, {"form": "D", "date": "2026-06-22", "title": "Form D", "accession": "0001104659-26-076151", "price_sensitive": false}, {"form": "8-K", "date": "2026-06-22", "title": "Material event", "accession": "0000926617-26-000047", "price_sensitive": true}, {"form": "8-K", "date": "2026-06-17", "title": "Material event", "accession": "0000926617-26-000045", "price_sensitive": true}, {"form": "SCHEDULE 13D/A", "date": "2026-06-11", "title": "Form SCHEDULE 13D/A", "accession": "0001493152-26-028278", "price_sensitive": false}, {"form": "4", "date": "2026-06-09", "title": "Insider transaction", "accession": "0001493152-26-027952", "price_sensitive": false}, {"form": "8-K", "date": "2026-06-09", "title": "Material event", "accession": "0000926617-26-000042", "price_sensitive": true}, {"form": "DEFA14A", "date": "2026-05-29", "title": "Form DEFA14A", "accession": "0000926617-26-000039", "price_sensitive": false}, {"form": "4", "date": "2026-05-29", "title": "Insider transaction", "accession": "0001493152-26-026359", "price_sensitive": false}, {"form": "4/A", "date": "2026-05-29", "title": "Form 4/A", "accession": "0001493152-26-026346", "price_sensitive": false}, {"form": "4/A", "date": "2026-05-29", "title": "Form 4/A", "accession": "0001493152-26-026345", "price_sensitive": false}, {"form": "8-K", "date": "2026-05-26", "title": "Material event", "accession": "0000926617-26-000037", "price_sensitive": true}, {"form": "10-Q", "date": "2026-05-15", "title": "Quarterly report", "accession": "0000926617-26-000033", "price_sensitive": true}, {"form": "8-K", "date": "2026-04-30", "title": "Material event", "accession": "0000926617-26-000029", "price_sensitive": true}, {"form": "ARS", "date": "2026-04-29", "title": "Form ARS", "accession": "0000926617-26-000027", "price_sensitive": false}, {"form": "DEFA14A", "date": "2026-04-28", "title": "Form DEFA14A", "accession": "0000926617-26-000025", "price_sensitive": false}, {"form": "DEF 14A", "date": "2026-04-24", "title": "Proxy statement", "accession": "0000926617-26-000023", "price_sensitive": false}, {"form": "10-K", "date": "2026-04-01", "title": "Annual report", "accession": "0000926617-26-000020", "price_sensitive": true}, {"form": "NT 10-K", "date": "2026-04-01", "title": "Form NT 10-K", "accession": "0000926617-26-000016", "price_sensitive": false}]}, "description": "AWH trades as AWH. Privy Trades holds 130 insider filings for the company, from May 2022 to July 2024. Across those, 14 insiders disclosed 26 open-market purchases totalling $825.69K against 1 sale totalling $3.30K. The most recent filing on record is dated 22 May 2025.", "exchange": null, "stats": {"buy_n": 26, "buy_sum": 825691.7216, "sell_n": 1, "sell_sum": 3302.6, "net": 822389.1216000001, "insiders": 14, "first_date": "2022-05-16", "last_date": "2024-07-09"}, "metrics": {"ticker": "AWH", "has_prices": false}, "trades": [{"id": "0001641172-25-012386", "src": "INSIDERS", "ticker": "AWH", "cik": "926617", "company": "Aspira Women's Health Inc.", "company_raw": "Aspira Women's Health Inc.", "who": "Michael William Buhle", "who_key": "Buhle Michael William", "role": "Chief Executive Officer", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "CEO files routine paperwork on AWH \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000164117225012386/0001641172-25-012386-index.htm", "trade_date": "2025-05-22", "timestamp": "2025-05-22", "mins": 762705}, {"id": "0001641172-25-002185", "src": "INSIDERS", "ticker": "AWH", "cik": "926617", "company": "Aspira Women's Health Inc.", "company_raw": "Aspira Women's Health Inc.", "who": "Celeste Rachelle Fralick", "who_key": "Fralick Celeste Rachelle", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "Director files routine paperwork on AWH \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000164117225002185/0001641172-25-002185-index.htm", "trade_date": "2025-03-31", "timestamp": "2025-03-31", "mins": 837585}, {"id": "0001641172-25-002186", "src": "INSIDERS", "ticker": "AWH", "cik": "926617", "company": "Aspira Women's Health Inc.", "company_raw": "Aspira Women's Health Inc.", "who": "Jannie Prestridge Herchuk", "who_key": "Herchuk Jannie Prestridge", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "Director files routine paperwork on AWH \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000164117225002186/0001641172-25-002186-index.htm", "trade_date": "2025-03-31", "timestamp": "2025-03-31", "mins": 837585}, {"id": "0001641172-25-002183", "src": "INSIDERS", "ticker": "AWH", "cik": "926617", "company": "Aspira Women's Health Inc.", "company_raw": "Aspira Women's Health Inc.", "who": "John Phillip Ragard", "who_key": "Ragard John Phillip", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "Director files routine paperwork on AWH \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000164117225002183/0001641172-25-002183-index.htm", "trade_date": "2025-03-31", "timestamp": "2025-03-31", "mins": 837585}, {"id": "0001641172-25-002184", "src": "INSIDERS", "ticker": "AWH", "cik": "926617", "company": "Aspira Women's Health Inc.", "company_raw": "Aspira Women's Health Inc.", "who": "Stefanie L. Cavanaugh", "who_key": "Cavanaugh Stefanie L.", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "Director files routine paperwork on AWH \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000164117225002184/0001641172-25-002184-index.htm", "trade_date": "2025-03-31", "timestamp": "2025-03-31", "mins": 837585}, {"id": "0001641172-25-002229", "src": "INSIDERS", "ticker": "AWH", "cik": "926617", "company": "Aspira Women's Health Inc.", "company_raw": "Aspira Women's Health Inc.", "who": "Ellen Beausang", "who_key": "Beausang Ellen", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "Director files routine paperwork on AWH \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000164117225002229/0001641172-25-002229-index.htm", "trade_date": "2025-03-31", "timestamp": "2025-03-31", "mins": 837585}, {"id": "0001641172-25-002231", "src": "INSIDERS", "ticker": "AWH", "cik": "926617", "company": "Aspira Women's Health Inc.", "company_raw": "Aspira Women's Health Inc.", "who": "Winfred Parnell", "who_key": "Parnell Winfred", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "Director files routine paperwork on AWH \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000164117225002231/0001641172-25-002231-index.htm", "trade_date": "2025-03-31", "timestamp": "2025-03-31", "mins": 837585}, {"id": "0001641172-25-002278", "src": "INSIDERS", "ticker": "AWH", "cik": "926617", "company": "Aspira Women's Health Inc.", "company_raw": "Aspira Women's Health Inc.", "who": "Ellen O'Connor Vos", "who_key": "Vos Ellen O'Connor", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "Director files routine paperwork on AWH \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000164117225002278/0001641172-25-002278-index.htm", "trade_date": "2025-03-31", "timestamp": "2025-03-31", "mins": 837585}, {"id": "0001641172-25-002227", "src": "INSIDERS", "ticker": "AWH", "cik": "926617", "company": "Aspira Women's Health Inc.", "company_raw": "Aspira Women's Health Inc.", "who": "Ellen Beausang", "who_key": "Beausang Ellen", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "Director files routine paperwork on AWH \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000164117225002227/0001641172-25-002227-index.htm", "trade_date": "2025-03-11", "timestamp": "2025-03-11", "mins": 866385}, {"id": "0000908834-25-000098", "src": "INSIDERS", "ticker": "AWH", "cik": "926617", "company": "Aspira Women's Health Inc.", "company_raw": "Aspira Women's Health Inc.", "who": "Jack W. Schuler", "who_key": "SCHULER JACK W", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "10% owner files routine paperwork on AWH \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000090883425000098/0000908834-25-000098-index.htm", "trade_date": "2025-03-06", "timestamp": "2025-03-06", "mins": 873585}, {"id": "0001859810-25-000002", "src": "INSIDERS", "ticker": "AWH", "cik": "926617", "company": "Aspira Women's Health Inc.", "company_raw": "Aspira Women's Health Inc.", "who": "Sandra Milligan", "who_key": "Milligan Sandra", "role": "Interim CEO", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 4449.2, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "CEO files routine paperwork on AWH \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000185981025000002/0001859810-25-000002-index.htm", "trade_date": "2025-01-08", "timestamp": "2025-01-08", "mins": 955665}, {"id": "0001562180-25-000277", "src": "INSIDERS", "ticker": "AWH", "cik": "926617", "company": "Aspira Women's Health Inc.", "company_raw": "Aspira Women's Health Inc.", "who": "Ellen O'Connor Vos", "who_key": "Vos Ellen O'Connor", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "Director files routine paperwork on AWH \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000156218025000277/0001562180-25-000277-index.htm", "trade_date": "2024-12-31", "timestamp": "2024-12-31", "mins": 967185}, {"id": "0001859810-25-000001", "src": "INSIDERS", "ticker": "AWH", "cik": "926617", "company": "Aspira Women's Health Inc.", "company_raw": "Aspira Women's Health Inc.", "who": "Sandra Milligan", "who_key": "Milligan Sandra", "role": "Interim CEO & President", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "CEO files routine paperwork on AWH \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000185981025000001/0001859810-25-000001-index.htm", "trade_date": "2024-12-31", "timestamp": "2024-12-31", "mins": 967185}, {"id": "0002031593-25-000001", "src": "INSIDERS", "ticker": "AWH", "cik": "926617", "company": "Aspira Women's Health Inc.", "company_raw": "Aspira Women's Health Inc.", "who": "John Phillip Ragard", "who_key": "Ragard John Phillip", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "Director files routine paperwork on AWH \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000203159325000001/0002031593-25-000001-index.htm", "trade_date": "2024-12-31", "timestamp": "2024-12-31", "mins": 967185}, {"id": "0001688530-25-000001", "src": "INSIDERS", "ticker": "AWH", "cik": "926617", "company": "Aspira Women's Health Inc.", "company_raw": "Aspira Women's Health Inc.", "who": "Stefanie L. Cavanaugh", "who_key": "Cavanaugh Stefanie L.", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "Director files routine paperwork on AWH \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000168853025000001/0001688530-25-000001-index.htm", "trade_date": "2024-12-31", "timestamp": "2024-12-31", "mins": 967185}, {"id": "0001979704-25-000001", "src": "INSIDERS", "ticker": "AWH", "cik": "926617", "company": "Aspira Women's Health Inc.", "company_raw": "Aspira Women's Health Inc.", "who": "Winfred Parnell", "who_key": "Parnell Winfred", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "Director files routine paperwork on AWH \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000197970425000001/0001979704-25-000001-index.htm", "trade_date": "2024-12-31", "timestamp": "2024-12-31", "mins": 967185}, {"id": "0001911051-25-000001", "src": "INSIDERS", "ticker": "AWH", "cik": "926617", "company": "Aspira Women's Health Inc.", "company_raw": "Aspira Women's Health Inc.", "who": "Celeste Rachelle Fralick", "who_key": "Fralick Celeste Rachelle", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "Director files routine paperwork on AWH \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000191105125000001/0001911051-25-000001-index.htm", "trade_date": "2024-12-31", "timestamp": "2024-12-31", "mins": 967185}, {"id": "0001973204-25-000001", "src": "INSIDERS", "ticker": "AWH", "cik": "926617", "company": "Aspira Women's Health Inc.", "company_raw": "Aspira Women's Health Inc.", "who": "Jannie Prestridge Herchuk", "who_key": "Herchuk Jannie Prestridge", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "Director files routine paperwork on AWH \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000197320425000001/0001973204-25-000001-index.htm", "trade_date": "2024-12-31", "timestamp": "2024-12-31", "mins": 967185}, {"id": "0001859810-24-000005", "src": "INSIDERS", "ticker": "AWH", "cik": "926617", "company": "Aspira Women's Health Inc.", "company_raw": "Aspira Women's Health Inc.", "who": "Sandra Milligan", "who_key": "Milligan Sandra", "role": "President", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "President files routine paperwork on AWH \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000185981024000005/0001859810-24-000005-index.htm", "trade_date": "2024-11-12", "timestamp": "2024-11-12", "mins": 1037745}, {"id": "0001562180-24-007697", "src": "INSIDERS", "ticker": "AWH", "cik": "926617", "company": "Aspira Women's Health Inc.", "company_raw": "Aspira Women's Health Inc.", "who": "John A. Kallassy", "who_key": "Kallassy John A", "role": "Interim CFO", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "CFO files routine paperwork on AWH \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000156218024007697/0001562180-24-007697-index.htm", "trade_date": "2024-11-12", "timestamp": "2024-11-12", "mins": 1037745}, {"id": "0001849521-24-000006", "src": "INSIDERS", "ticker": "AWH", "cik": "926617", "company": "Aspira Women's Health Inc.", "company_raw": "Aspira Women's Health Inc.", "who": "Nicole Sandford", "who_key": "Sandford Nicole", "role": "Chief Executive Officer, Director", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "CEO files routine paperwork on AWH \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000184952124000006/0001849521-24-000006-index.htm", "trade_date": "2024-10-28", "timestamp": "2024-10-28", "mins": 1059345}, {"id": "0001859810-24-000004", "src": "INSIDERS", "ticker": "AWH", "cik": "926617", "company": "Aspira Women's Health Inc.", "company_raw": "Aspira Women's Health Inc.", "who": "Sandra Milligan", "who_key": "Milligan Sandra", "role": "President", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "President files routine paperwork on AWH \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000185981024000004/0001859810-24-000004-index.htm", "trade_date": "2024-10-28", "timestamp": "2024-10-28", "mins": 1059345}, {"id": "0001911051-24-000001", "src": "INSIDERS", "ticker": "AWH", "cik": "926617", "company": "Aspira Women's Health Inc.", "company_raw": "Aspira Women's Health Inc.", "who": "Celeste Rachelle Fralick", "who_key": "Fralick Celeste Rachelle", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "Director files routine paperwork on AWH \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000191105124000001/0001911051-24-000001-index.htm", "trade_date": "2024-09-30", "timestamp": "2024-09-30", "mins": 1099665}, {"id": "0002031593-24-000001", "src": "INSIDERS", "ticker": "AWH", "cik": "926617", "company": "Aspira Women's Health Inc.", "company_raw": "Aspira Women's Health Inc.", "who": "John Phillip Ragard", "who_key": "Ragard John Phillip", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "Director files routine paperwork on AWH \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000203159324000001/0002031593-24-000001-index.htm", "trade_date": "2024-09-30", "timestamp": "2024-09-30", "mins": 1099665}, {"id": "0001973204-24-000001", "src": "INSIDERS", "ticker": "AWH", "cik": "926617", "company": "Aspira Women's Health Inc.", "company_raw": "Aspira Women's Health Inc.", "who": "Jannie Prestridge Herchuk", "who_key": "Herchuk Jannie Prestridge", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "Director files routine paperwork on AWH \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000197320424000001/0001973204-24-000001-index.htm", "trade_date": "2024-09-30", "timestamp": "2024-09-30", "mins": 1099665}, {"id": "0001979704-24-000001", "src": "INSIDERS", "ticker": "AWH", "cik": "926617", "company": "Aspira Women's Health Inc.", "company_raw": "Aspira Women's Health Inc.", "who": "Winfred Parnell", "who_key": "Parnell Winfred", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "Director files routine paperwork on AWH \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000197970424000001/0001979704-24-000001-index.htm", "trade_date": "2024-09-30", "timestamp": "2024-09-30", "mins": 1099665}, {"id": "0001688530-24-000002", "src": "INSIDERS", "ticker": "AWH", "cik": "926617", "company": "Aspira Women's Health Inc.", "company_raw": "Aspira Women's Health Inc.", "who": "Stefanie L. Cavanaugh", "who_key": "Cavanaugh Stefanie L.", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "Director files routine paperwork on AWH \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000168853024000002/0001688530-24-000002-index.htm", "trade_date": "2024-09-30", "timestamp": "2024-09-30", "mins": 1099665}, {"id": "0001562180-24-007233", "src": "INSIDERS", "ticker": "AWH", "cik": "926617", "company": "Aspira Women's Health Inc.", "company_raw": "Aspira Women's Health Inc.", "who": "Ellen O'Connor Vos", "who_key": "Vos Ellen O'Connor", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "Director files routine paperwork on AWH \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000156218024007233/0001562180-24-007233-index.htm", "trade_date": "2024-09-30", "timestamp": "2024-09-30", "mins": 1099665}, {"id": "0002031593-24-000002", "src": "INSIDERS", "ticker": "AWH", "cik": "926617", "company": "Aspira Women's Health Inc.", "company_raw": "Aspira Women's Health Inc.", "who": "John Phillip Ragard", "who_key": "Ragard John Phillip", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "Director files routine paperwork on AWH \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000203159324000002/0002031593-24-000002-index.htm", "trade_date": "2024-09-30", "timestamp": "2024-09-30", "mins": 1099665}, {"id": "0000950170-24-100336", "src": "INSIDERS", "ticker": "AWH", "cik": "926617", "company": "Aspira Women's Health Inc.", "company_raw": "Aspira Women's Health Inc.", "who": "Stefanie L. Cavanaugh", "who_key": "Cavanaugh Stefanie L.", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "Director files routine paperwork on AWH \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000095017024100336/0000950170-24-100336-index.htm", "trade_date": "2024-08-22", "timestamp": "2024-08-22", "mins": 1155825}], "recent_buys": [{"id": "0000908834-24-000179", "src": "INSIDERS", "ticker": "AWH", "cik": "926617", "company": "Aspira Women's Health Inc.", "company_raw": "Aspira Women's Health Inc.", "who": "Jack W. Schuler", "who_key": "SCHULER JACK W", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "BUY", "amount": 0.0, "score": 12.5, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "Big holder adds $0 of AWH", "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000090883424000179/0000908834-24-000179-index.htm", "trade_date": "2024-07-09", "timestamp": "2024-07-09", "mins": 1219185}, {"id": "0001849521-24-000004", "src": "INSIDERS", "ticker": "AWH", "cik": "926617", "company": "Aspira Women's Health Inc.", "company_raw": "Aspira Women's Health Inc.", "who": "Nicole Sandford", "who_key": "Sandford Nicole", "role": "Chief Executive Officer, Director", "person_type": "CEO", "person_label": "CEOs", "action": "BUY", "amount": 22973.059999999998, "score": 43.9, "price_sensitive": true, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "CEO buys $23K of AWH", "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000184952124000004/0001849521-24-000004-index.htm", "trade_date": "2024-05-31", "timestamp": "2024-05-31", "mins": 1275345}, {"id": "0000908834-24-000171", "src": "INSIDERS", "ticker": "AWH", "cik": "926617", "company": "Aspira Women's Health Inc.", "company_raw": "Aspira Women's Health Inc.", "who": "Jack W. Schuler", "who_key": "SCHULER JACK W", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "BUY", "amount": 0.0, "score": 12.7, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "Big holder adds $0 of AWH", "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000090883424000171/0000908834-24-000171-index.htm", "trade_date": "2024-01-26", "timestamp": "2024-01-26", "mins": 1456785}, {"id": "0001849521-24-000001", "src": "INSIDERS", "ticker": "AWH", "cik": "926617", "company": "Aspira Women's Health Inc.", "company_raw": "Aspira Women's Health Inc.", "who": "Nicole Sandford", "who_key": "Sandford Nicole", "role": "President & CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "BUY", "amount": 0.0, "score": 25.6, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "Insider cluster: 3 buying AWH", "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000184952124000001/0001849521-24-000001-index.htm", "trade_date": "2024-01-26", "timestamp": "2024-01-26", "mins": 1456785}, {"id": "0001849521-23-000009", "src": "INSIDERS", "ticker": "AWH", "cik": "926617", "company": "Aspira Women's Health Inc.", "company_raw": "Aspira Women's Health Inc.", "who": "Nicole Sandford", "who_key": "Sandford Nicole", "role": "President & CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "BUY", "amount": 16800.0, "score": 41.4, "price_sensitive": true, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "3 insiders now buying AWH", "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000184952123000009/0001849521-23-000009-index.htm", "trade_date": "2023-12-06", "timestamp": "2023-12-06", "mins": 1530225}, {"id": "0001983682-23-000004", "src": "INSIDERS", "ticker": "AWH", "cik": "926617", "company": "Aspira Women's Health Inc.", "company_raw": "Aspira Women's Health Inc.", "who": "Torsten Hombeck", "who_key": "Hombeck Torsten", "role": "Chief Financial Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "BUY", "amount": 9657.8, "score": 49.8, "price_sensitive": true, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "That makes 3 insiders into AWH", "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000198368223000004/0001983682-23-000004-index.htm", "trade_date": "2023-09-08", "timestamp": "2023-09-08", "mins": 1658385}, {"id": "0001911051-23-000002", "src": "INSIDERS", "ticker": "AWH", "cik": "926617", "company": "Aspira Women's Health Inc.", "company_raw": "Aspira Women's Health Inc.", "who": "Celeste Rachelle Fralick", "who_key": "Fralick Celeste Rachelle", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 3000.92, "score": 23.2, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "That makes 4 insiders into AWH", "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000191105123000002/0001911051-23-000002-index.htm", "trade_date": "2023-07-24", "timestamp": "2023-07-24", "mins": 1724625}, {"id": "0000926617-23-000061", "src": "INSIDERS", "ticker": "AWH", "cik": "926617", "company": "Aspira Women's Health Inc.", "company_raw": "Aspira Women's Health Inc.", "who": "Ellen O'Connor Vos", "who_key": "Vos Ellen O'Connor", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 15000.62, "score": 31.4, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "That makes 5 insiders into AWH", "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000092661723000061/0000926617-23-000061-index.htm", "trade_date": "2023-07-24", "timestamp": "2023-07-24", "mins": 1724625}, {"id": "0000908834-23-000088", "src": "INSIDERS", "ticker": "AWH", "cik": "926617", "company": "Aspira Women's Health Inc.", "company_raw": "Aspira Women's Health Inc.", "who": "Jack W. Schuler", "who_key": "SCHULER JACK W", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "BUY", "amount": 499950.0, "score": 46.5, "price_sensitive": true, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "That makes 6 insiders into AWH", "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000090883423000088/0000908834-23-000088-index.htm", "trade_date": "2023-07-24", "timestamp": "2023-07-24", "mins": 1724625}, {"id": "0001688530-23-000002", "src": "INSIDERS", "ticker": "AWH", "cik": "926617", "company": "Aspira Women's Health Inc.", "company_raw": "Aspira Women's Health Inc.", "who": "Stefanie L. Cavanaugh", "who_key": "Cavanaugh Stefanie L.", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 24998.38, "score": 35.3, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "6 insiders now buying AWH", "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000168853023000002/0001688530-23-000002-index.htm", "trade_date": "2023-07-24", "timestamp": "2023-07-24", "mins": 1724625}, {"id": "0001849521-23-000004", "src": "INSIDERS", "ticker": "AWH", "cik": "926617", "company": "Aspira Women's Health Inc.", "company_raw": "Aspira Women's Health Inc.", "who": "Nicole Sandford", "who_key": "Sandford Nicole", "role": "President & CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "BUY", "amount": 50000.74, "score": 47.0, "price_sensitive": true, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "Insider cluster: 7 buying AWH", "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000184952123000004/0001849521-23-000004-index.htm", "trade_date": "2023-07-24", "timestamp": "2023-07-24", "mins": 1724625}, {"id": "0001937660-23-000003", "src": "INSIDERS", "ticker": "AWH", "cik": "926617", "company": "Aspira Women's Health Inc.", "company_raw": "Aspira Women's Health Inc.", "who": "Ryan Thinh Phan", "who_key": "Phan Ryan Thinh", "role": "CSO & COO", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "BUY", "amount": 2499.44, "score": 19.4, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "That makes 7 insiders into AWH", "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000193766023000003/0001937660-23-000003-index.htm", "trade_date": "2023-07-24", "timestamp": "2023-07-24", "mins": 1724625}], "institutional": [], "holdings": [], "directors": [], "status": {"status": "delisted", "exchange": null, "note": "No longer in the live ASX listing \u2014 delisted, acquired or merged. Historical filings are retained here; live price history ends at delisting."}, "corporate_actions": {"status_label": "No longer listed", "items": [{"action": "DELISTED", "reason": "UNKNOWN", "counterparty": null, "old_value": "AWH", "new_value": "No longer listed", "effective": "", "evidence": "No longer in the listed universe; we have no source stating why.", "source_url": "", "applied": 1, "detected_at": "2026-08-03T11:13:39.852250"}]}, "key_people": [{"who": "Jack W. Schuler", "who_key": "SCHULER JACK W", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "bought": 499950.0, "sold": 0, "net": 499950.0, "trades": 4, "top_score": 46.5, "lean": "buying", "history": [{"action": "BUY", "amount": 0, "date": "2024-07-09", "score": 12.5, "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000090883424000179/0000908834-24-000179-index.htm"}, {"action": "BUY", "amount": 0, "date": "2024-01-26", "score": 12.7, "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000090883424000171/0000908834-24-000171-index.htm"}, {"action": "BUY", "amount": 499950.0, "date": "2023-07-24", "score": 46.5, "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000090883423000088/0000908834-23-000088-index.htm"}, {"action": "BUY", "amount": 0, "date": "2022-08-25", "score": 12.6, "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000114036122031345/0001140361-22-031345-index.htm"}], "latest": {"action": "BUY", "amount": 0, "date": "2024-07-09", "score": 12.5, "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000090883424000179/0000908834-24-000179-index.htm"}}, {"who": "Nicole Sandford", "who_key": "Sandford Nicole", "role": "President and CEO, Director", "person_type": "CEO", "person_label": "CEOs", "bought": 164665.4, "sold": 0, "net": 164665.4, "trades": 6, "top_score": 62.6, "lean": "buying", "history": [{"action": "BUY", "amount": 22973.059999999998, "date": "2024-05-31", "score": 43.9, "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000184952124000004/0001849521-24-000004-index.htm"}, {"action": "BUY", "amount": 0, "date": "2024-01-26", "score": 25.6, "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000184952124000001/0001849521-24-000001-index.htm"}, {"action": "BUY", "amount": 16800.0, "date": "2023-12-06", "score": 41.4, "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000184952123000009/0001849521-23-000009-index.htm"}, {"action": "BUY", "amount": 50000.74, "date": "2023-07-24", "score": 47.0, "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000184952123000004/0001849521-23-000004-index.htm"}, {"action": "BUY", "amount": 0, "date": "2022-08-25", "score": 40.0, "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000184952122000009/0001849521-22-000009-index.htm"}, {"action": "BUY", "amount": 74891.6, "date": "2022-05-16", "score": 62.6, "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000184952122000005/0001849521-22-000005-index.htm"}], "latest": {"action": "BUY", "amount": 22973.059999999998, "date": "2024-05-31", "score": 43.9, "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000184952124000004/0001849521-24-000004-index.htm"}}, {"who": "Jannie Prestridge Herchuk", "who_key": "Herchuk Jannie Prestridge", "role": "Director", "person_type": "BOARD", "person_label": "Board", "bought": 35000.12, "sold": 0, "net": 35000.12, "trades": 1, "top_score": 42.4, "lean": "buying", "history": [{"action": "BUY", "amount": 35000.12, "date": "2023-07-24", "score": 42.4, "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000197320423000002/0001973204-23-000002-index.htm"}], "latest": {"action": "BUY", "amount": 35000.12, "date": "2023-07-24", "score": 42.4, "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000197320423000002/0001973204-23-000002-index.htm"}}, {"who": "Winfred Parnell", "who_key": "Parnell Winfred", "role": "Director", "person_type": "BOARD", "person_label": "Board", "bought": 24998.38, "sold": 0, "net": 24998.38, "trades": 1, "top_score": 35.7, "lean": "buying", "history": [{"action": "BUY", "amount": 24998.38, "date": "2023-07-24", "score": 35.7, "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000197970423000003/0001979704-23-000003-index.htm"}], "latest": {"action": "BUY", "amount": 24998.38, "date": "2023-07-24", "score": 35.7, "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000197970423000003/0001979704-23-000003-index.htm"}}, {"who": "Stefanie L. Cavanaugh", "who_key": "Cavanaugh Stefanie L.", "role": "Director", "person_type": "BOARD", "person_label": "Board", "bought": 24998.38, "sold": 0, "net": 24998.38, "trades": 1, "top_score": 35.3, "lean": "buying", "history": [{"action": "BUY", "amount": 24998.38, "date": "2023-07-24", "score": 35.3, "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000168853023000002/0001688530-23-000002-index.htm"}], "latest": {"action": "BUY", "amount": 24998.38, "date": "2023-07-24", "score": 35.3, "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000168853023000002/0001688530-23-000002-index.htm"}}, {"who": "Valerie Barber Palmieri", "who_key": "Palmieri Valerie Barber", "role": "Executive Chair, Director", "person_type": "EXEC", "person_label": "Execs", "bought": 24918.2016, "sold": 0, "net": 24918.2016, "trades": 1, "top_score": 34.9, "lean": "buying", "history": [{"action": "BUY", "amount": 24918.2016, "date": "2022-05-16", "score": 34.9, "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000162301722000001/0001623017-22-000001-index.htm"}], "latest": {"action": "BUY", "amount": 24918.2016, "date": "2022-05-16", "score": 34.9, "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000162301722000001/0001623017-22-000001-index.htm"}}, {"who": "Ellen O'Connor Vos", "who_key": "Vos Ellen O'Connor", "role": "Director", "person_type": "BOARD", "person_label": "Board", "bought": 15000.62, "sold": 0, "net": 15000.62, "trades": 1, "top_score": 31.4, "lean": "buying", "history": [{"action": "BUY", "amount": 15000.62, "date": "2023-07-24", "score": 31.4, "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000092661723000061/0000926617-23-000061-index.htm"}], "latest": {"action": "BUY", "amount": 15000.62, "date": "2023-07-24", "score": 31.4, "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000092661723000061/0000926617-23-000061-index.htm"}}, {"who": "Veronica Gh Jordan", "who_key": "Jordan Veronica GH", "role": "Director", "person_type": "BOARD", "person_label": "Board", "bought": 15000.62, "sold": 0, "net": 15000.62, "trades": 1, "top_score": 31.3, "lean": "buying", "history": [{"action": "BUY", "amount": 15000.62, "date": "2023-07-24", "score": 31.3, "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000138112323000003/0001381123-23-000003-index.htm"}], "latest": {"action": "BUY", "amount": 15000.62, "date": "2023-07-24", "score": 31.3, "source_url": "https://www.sec.gov/Archives/edgar/data/926617/000138112323000003/0001381123-23-000003-index.htm"}}], "activity": [], "announcements": [{"form": "4", "date": "2026-10-02", "title": "Insider transaction", "accession": "0001493152-26-045579", "price_sensitive": false}, {"form": "10-Q", "date": "2026-08-14", "title": "Quarterly report", "accession": "0000926617-26-000054", "price_sensitive": true}, {"form": "4/A", "date": "2026-07-17", "title": "Form 4/A", "accession": "0001493152-26-033814", "price_sensitive": false}, {"form": "4", "date": "2026-07-15", "title": "Insider transaction", "accession": "0001493152-26-033384", "price_sensitive": false}, {"form": "8-K", "date": "2026-07-15", "title": "Material event", "accession": "0000926617-26-000052", "price_sensitive": true}, {"form": "3", "date": "2026-07-15", "title": "Initial insider holdings", "accession": "0001493152-26-033355", "price_sensitive": false}, {"form": "8-K/A", "date": "2026-07-07", "title": "Form 8-K/A", "accession": "0000926617-26-000050", "price_sensitive": false}, {"form": "D", "date": "2026-06-22", "title": "Form D", "accession": "0001104659-26-076151", "price_sensitive": false}, {"form": "8-K", "date": "2026-06-22", "title": "Material event", "accession": "0000926617-26-000047", "price_sensitive": true}, {"form": "8-K", "date": "2026-06-17", "title": "Material event", "accession": "0000926617-26-000045", "price_sensitive": true}, {"form": "SCHEDULE 13D/A", "date": "2026-06-11", "title": "Form SCHEDULE 13D/A", "accession": "0001493152-26-028278", "price_sensitive": false}, {"form": "4", "date": "2026-06-09", "title": "Insider transaction", "accession": "0001493152-26-027952", "price_sensitive": false}, {"form": "8-K", "date": "2026-06-09", "title": "Material event", "accession": "0000926617-26-000042", "price_sensitive": true}, {"form": "DEFA14A", "date": "2026-05-29", "title": "Form DEFA14A", "accession": "0000926617-26-000039", "price_sensitive": false}, {"form": "4", "date": "2026-05-29", "title": "Insider transaction", "accession": "0001493152-26-026359", "price_sensitive": false}, {"form": "4/A", "date": "2026-05-29", "title": "Form 4/A", "accession": "0001493152-26-026346", "price_sensitive": false}, {"form": "4/A", "date": "2026-05-29", "title": "Form 4/A", "accession": "0001493152-26-026345", "price_sensitive": false}, {"form": "8-K", "date": "2026-05-26", "title": "Material event", "accession": "0000926617-26-000037", "price_sensitive": true}, {"form": "10-Q", "date": "2026-05-15", "title": "Quarterly report", "accession": "0000926617-26-000033", "price_sensitive": true}, {"form": "8-K", "date": "2026-04-30", "title": "Material event", "accession": "0000926617-26-000029", "price_sensitive": true}, {"form": "ARS", "date": "2026-04-29", "title": "Form ARS", "accession": "0000926617-26-000027", "price_sensitive": false}, {"form": "DEFA14A", "date": "2026-04-28", "title": "Form DEFA14A", "accession": "0000926617-26-000025", "price_sensitive": false}, {"form": "DEF 14A", "date": "2026-04-24", "title": "Proxy statement", "accession": "0000926617-26-000023", "price_sensitive": false}, {"form": "10-K", "date": "2026-04-01", "title": "Annual report", "accession": "0000926617-26-000020", "price_sensitive": true}, {"form": "NT 10-K", "date": "2026-04-01", "title": "Form NT 10-K", "accession": "0000926617-26-000016", "price_sensitive": false}], "performance": {"ticker": "AWH", "has_prices": false, "summary": null, "buys": [{"who": "SCHULER JACK W", "person_type": "TEN_PCT", "person_label": "10% Owners", "role": "10% Owner", "amount": 0.0, "date": "2024-07-09", "score": 12.5, "ref_price": null, "return": null}, {"who": "Sandford Nicole", "person_type": "CEO", "person_label": "CEOs", "role": "Chief Executive Officer, Director", "amount": 22973.059999999998, "date": "2024-05-31", "score": 43.9, "ref_price": null, "return": null}, {"who": "SCHULER JACK W", "person_type": "TEN_PCT", "person_label": "10% Owners", "role": "10% Owner", "amount": 0.0, "date": "2024-01-26", "score": 12.7, "ref_price": null, "return": null}, {"who": "Sandford Nicole", "person_type": "CEO", "person_label": "CEOs", "role": "President & CEO, Director", "amount": 0.0, "date": "2024-01-26", "score": 25.6, "ref_price": null, "return": null}, {"who": "Sandford Nicole", "person_type": "CEO", "person_label": "CEOs", "role": "President & CEO, Director", "amount": 16800.0, "date": "2023-12-06", "score": 41.4, "ref_price": null, "return": null}, {"who": "Hombeck Torsten", "person_type": "C_SUITE", "person_label": "C-Suite", "role": "Chief Financial Officer", "amount": 9657.8, "date": "2023-09-08", "score": 49.8, "ref_price": null, "return": null}, {"who": "Fralick Celeste Rachelle", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 3000.92, "date": "2023-07-24", "score": 23.2, "ref_price": null, "return": null}, {"who": "Vos Ellen O'Connor", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 15000.62, "date": "2023-07-24", "score": 31.4, "ref_price": null, "return": null}, {"who": "SCHULER JACK W", "person_type": "TEN_PCT", "person_label": "10% Owners", "role": "10% Owner", "amount": 499950.0, "date": "2023-07-24", "score": 46.5, "ref_price": null, "return": null}, {"who": "Cavanaugh Stefanie L.", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 24998.38, "date": "2023-07-24", "score": 35.3, "ref_price": null, "return": null}, {"who": "Sandford Nicole", "person_type": "CEO", "person_label": "CEOs", "role": "President & CEO, Director", "amount": 50000.74, "date": "2023-07-24", "score": 47.0, "ref_price": null, "return": null}, {"who": "Phan Ryan Thinh", "person_type": "C_SUITE", "person_label": "C-Suite", "role": "CSO & COO", "amount": 2499.44, "date": "2023-07-24", "score": 19.4, "ref_price": null, "return": null}, {"who": "Parnell Winfred", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 24998.38, "date": "2023-07-24", "score": 35.7, "ref_price": null, "return": null}, {"who": "Merchant Minh Hoang", "person_type": "EXEC", "person_label": "Execs", "role": "General counsel and secretary", "amount": 3000.92, "date": "2023-07-24", "score": 20.9, "ref_price": null, "return": null}, {"who": "Jordan Veronica GH", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 15000.62, "date": "2023-07-24", "score": 31.3, "ref_price": null, "return": null}, {"who": "Hombeck Torsten", "person_type": "C_SUITE", "person_label": "C-Suite", "role": "Chief Financial Officer", "amount": 3000.92, "date": "2023-07-24", "score": 29.7, "ref_price": null, "return": null}, {"who": "Herchuk Jannie Prestridge", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 35000.12, "date": "2023-07-24", "score": 42.4, "ref_price": null, "return": null}, {"who": "Merchant Minh Hoang", "person_type": "EXEC", "person_label": "Execs", "role": "General Counsel & Secretary", "amount": 0.0, "date": "2022-08-25", "score": 25.0, "ref_price": null, "return": null}, {"who": "Fralick Celeste Rachelle", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 0.0, "date": "2022-08-25", "score": 16.0, "ref_price": null, "return": null}, {"who": "Auerbach Robert D", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 0.0, "date": "2022-08-25", "score": 30.0, "ref_price": null, "return": null}, {"who": "Phan Ryan Thinh", "person_type": "C_SUITE", "person_label": "C-Suite", "role": "CSO & COO", "amount": 0.0, "date": "2022-08-25", "score": 25.0, "ref_price": null, "return": null}, {"who": "Sharma Ruby", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 0.0, "date": "2022-08-25", "score": 16.8, "ref_price": null, "return": null}, {"who": "Sandford Nicole", "person_type": "CEO", "person_label": "CEOs", "role": "President & CEO, Director", "amount": 0.0, "date": "2022-08-25", "score": 40.0, "ref_price": null, "return": null}, {"who": "SCHULER JACK W", "person_type": "TEN_PCT", "person_label": "10% Owners", "role": "10% Owner", "amount": 0.0, "date": "2022-08-25", "score": 12.6, "ref_price": null, "return": null}, {"who": "Palmieri Valerie Barber", "person_type": "EXEC", "person_label": "Execs", "role": "Executive Chair, Director", "amount": 24918.2016, "date": "2022-05-16", "score": 34.9, "ref_price": null, "return": null}, {"who": "Sandford Nicole", "person_type": "CEO", "person_label": "CEOs", "role": "President and CEO, Director", "amount": 74891.6, "date": "2022-05-16", "score": 62.6, "ref_price": null, "return": null}]}, "price_series": [], "refreshing": true}